BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 104,315 | $739 | 0.00% |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | $0 | 0.00% |
| HARBOUR INVESTMENTS, INC. | 51 | $361 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 5,325 | $37,701 | 0.00% |
| Bell Investment Advisors, Inc | 132 | $935 | 0.00% |
| Steward Financial Group LLC | 8 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 99,711 | $705,954 | 0.00% |
| CITIGROUP INC | 39,900 | $282,492 | 0.00% |
| CITIGROUP INC | 39,900 | $282,492 | 0.00% |
| CWM, LLC | 3,531 | $25 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 20,408 | $144,489 | 0.00% |
| SJS Investment Consulting Inc. | 25 | $177 | 0.00% |
| HSBC HOLDINGS PLC | 18,875 | $133,824 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 68 | $482 | 0.00% |
| Allworth Financial LP | 499 | $3,533 | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 200 | $1,416 | 0.00% |
| QUADRANT CAPITAL GROUP LLC | 333 | $2,358 | 0.00% |
| ASSETMARK, INC | 1,950 | $13,806 | 0.00% |
| Financial Gravity Asset Management, Inc. | 2 | $10 | 0.00% |
| TFO Wealth Partners, LLC | 3 | $21 | 0.00% |
External links
This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.